Chief Executive Officer of Teva-Handok, Hong Yoo-Suk was elected as a president of GSK Korea

Published: 2014-07-23 09:25:03

Updated: 2014-07-23 09:25:03

Chief Executive Officer of Teva-Handok, Hong Yoo-Suk was elected as a president of GSK Korea. Kim Jin-ho, the current representative director of GlaxoSmithKline Korea was elected as chairman.

Chairman Kim Jin-ho was promoted to senior vice president of GSK group in 2012, and took over North Asia regional headquarters where GSK Korea is included.

New president Hong Yoo-Suk joined Eli Lilly in ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.